Clinical Trial Update: A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse [Phase 1, Phase 2]

View source ↗

Summary

Two-stage Phase 1/2 trial of lenalidomide in asymptomatic patients with recurrent ovarian cancer and rising CA-125 in late relapse has been completed, evaluatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer Recurrent | Phase 1, Phase 2 | Status: COMPLETED